NCT02173327

Brief Summary

Postoperative pulmonal complications (Abbreviation - PPC) after major abdominal surgery remains a significant clinical problem delaying rehabilitation after surgery. CPAP is one approach to minimize the frequency and severeness of PPC. In the investigators' organization intermittent mask CPAP every 2 hour, 15min, is used routineously after major abdominal surgery. Recently new devices has been designed, which give the opportunity tip deliver continuously CPAP with out interruptions because of presumed better comfort. Therefore better patient compliance. No studies to date have investigated the possible benefit of using continuously helm CPAP versus the traditional intermittent mask CPAP after major abdominal surgery. The investigators' study will investigate if there are any benefits with continuously Helm CPAP Versus intermittent Mask CPAP After Major Abdominal Surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

June 18, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 24, 2014

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
Last Updated

June 24, 2014

Status Verified

June 1, 2014

Enrollment Period

1 year

First QC Date

June 18, 2014

Last Update Submit

June 23, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • PaO2/FiO2

    Measured 6,12 and 18 hours after surgery

    24 hours

Secondary Outcomes (5)

  • V/Q mismatch

    24 hours

  • Postoperative complications

    30 days

  • Length of stay

    30 days

  • Admittance to the intensive care unit

    30 days

  • Mortality

    30 days

Other Outcomes (3)

  • Total CPAP therapy time

    24 timer

  • CPAP interruptions

    24 timer

  • Comfort during CPAP therapy

    24 timer

Study Arms (2)

Continuously Helm CPAP

OTHER

Continuously helm CPAP for 6 hours

Device: Continuously helm CPAP

Intermittent Mask CPAP

OTHER

Intermittent Mask CPAP for 10minuttes every 2 hours in a 18 hours period postoperative.

Device: Intermittent Mask CPAP

Interventions

6 hours

Continuously Helm CPAP

10min every 2 hour for 18 hours

Intermittent Mask CPAP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective major abdominal surgery

You may not qualify if:

  • Severe lung disease. Airway deformity. Need for CPAP at home. Ongoing oxygen therapy. Cannot give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rigshospitalet

Copenhagen, 2100, Denmark

RECRUITING

Related Publications (1)

  • Osterkamp JTF, Strandby RB, Henningsen L, Marcussen KV, Thomsen T, Mortensen CR, Achiam MP, Jans O. Comparing the effects of continuous positive airway pressure via mask or helmet interface on oxygenation and pulmonary complications after major abdominal surgery: a randomized trial. J Clin Monit Comput. 2023 Feb;37(1):63-70. doi: 10.1007/s10877-022-00857-7. Epub 2022 Apr 16.

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Officials

  • Christian R Mortensen, MD

    Rigshospitalet, Denmark

    STUDY CHAIR

Central Study Contacts

Klaus V Marcussen, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

June 18, 2014

First Posted

June 24, 2014

Study Start

November 1, 2013

Primary Completion

November 1, 2014

Study Completion

April 1, 2016

Last Updated

June 24, 2014

Record last verified: 2014-06

Locations